Sociedad Química y Minera de Chile S.A. operates as a Santiago-based producer of specialty chemicals and minerals, with activities across lithium, iodine, specialty plant nutrition, potassium, and industrial chemicals. The company draws these resources from high-quality salt brine deposits and caliche ore, centered on its Salar de Atacama operation in Chile, which stands among the world's lowest-cost lithium sources.
Lithium forms the most closely followed segment, providing battery-grade lithium carbonate and hydroxide for electric vehicles and energy-storage systems. SQM develops lithium through its Novandino joint venture with Chilean state-owned Codelco, in addition to a hard-rock lithium joint venture in Australia and refining assets in China. Beyond lithium, SQM ranks as a leading global supplier of iodine for X-ray contrast media and of specialty potassium and sodium nitrate fertilizers. Investors track the stock for its ties to the energy transition, its diversified commodity exposure, and its low-cost production base. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, SQM advanced from a closing price of about $67.06 to roughly $79, an increase of approximately 17.8%. The move was not entirely steady: the stock rallied through mid-August after earnings, reached an intraday peak near $84.50 on August 21, and then consolidated modestly toward the end of the period.
The trailing quarter showed more volatility. Earlier in the quarter, SQM traded near its 52-week high of $98.00 reached in May, before selling pressure pulled the stock into the $65–$67 range by mid-July. The earnings-driven rebound that followed narrowed the decline, leaving the stock roughly 8% lower over the trailing three months measured from late May. This pattern reflects a repricing as lithium fundamentals improved after a stretch of oversupply-related weakness.
The main catalyst came from the company's second-quarter 2026 earnings report, released on August 18. SQM posted revenue of $2.47 billion—up about 137% year over year and roughly 10% above consensus—alongside net income of $660 million and adjusted EPS of $2.31, comfortably ahead of the approximately $2.04 estimate. Adjusted EBITDA more than quadrupled year over year.
Lithium stood out. Segment revenue climbed roughly 300% year over year to about $1.78 billion, supported by record sales volume above 84,000 metric tons of lithium carbonate equivalent. The realized price at the Novandino joint venture reached about $21.80 per kilogram, up roughly 23% from the prior quarter and about 160% higher than a year earlier. Management also raised its full-year global lithium demand forecast to more than 2.1 million metric tons.
Iodine added further support, posting a second straight record quarter with average realized prices near $73.40 per kilogram. The combination of stronger-than-expected results and a more constructive lithium outlook outweighed initial “sell-the-news” profit-taking and valuation concerns that briefly pressured the shares after the report. From what I see, this earnings beat provided clear confirmation of improving fundamentals.
The wider quarterly trend was shaped by the lithium price cycle. Through the spring, SQM benefited from a rebound in lithium markets as demand from battery storage and electric vehicles outpaced expectations. However, lingering oversupply worries and profit-taking pushed the stock from its May peak into the mid-$60s by July.
The recovery that followed rested on improving fundamentals: firmer realized lithium prices, record volumes, and resilient iodine pricing. Progress and growing clarity around the Codelco joint venture also helped ease regulatory uncertainty, while the company's low-cost Salar de Atacama asset supported its competitive position. The net effect was a quarter of wide swings that ended with the stock regaining much—but not all—of its earlier losses.
Looking ahead, the most important factors for SQM include the trajectory of lithium prices and demand, particularly from electric-vehicle and battery-storage markets. Third-quarter results are scheduled for November 2026, and investors will focus on realized pricing, sales volumes, and any updates to full-year lithium demand and production guidance.
Other key variables include iodine supply dynamics—management has indicated third-party supply could increase into year-end—as well as the terms and execution of the Codelco joint venture, Chilean royalty and regulatory policies, and broader macroeconomic conditions, including demand from China. Competitive supply from peers such as Albemarle (ALB) will also influence the pricing environment. These factors will shape sentiment without guaranteeing any particular outcome. I’m watching this closely as the Codelco partnership developments unfold.
In my own research process, I occasionally review Tickeron’s Trending AI Robots to compare algorithmic approaches across different timeframes and market conditions. The page highlights top-performing bots that monitor thousands of tickers, allowing a clearer view of how systematic strategies align with names like SQM and broader sector trends. This helps round out fundamental analysis without replacing it.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SQM advanced for three days, in 223 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SQM's RSI Oscillator exited the oversold zone, 18 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
SQM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
SQM moved below its 50-day moving average on September 11, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SQM crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SQM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for SQM entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.949) is normal, around the industry mean (6.363). P/E Ratio (13.410) is within average values for comparable stocks, (209.940). Projected Growth (PEG Ratio) (0.300) is also within normal values, averaging (1.548). SQM has a moderately high Dividend Yield (0.037) as compared to the industry average of (0.013). P/S Ratio (2.917) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. SQM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SQM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a producer of potassium nitrate and iodine chemicals
Industry ChemicalsSpecialty